Inpharmatis
Inpharmatis is a Latvia-based international consulting group providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, and PIL readability testing to pharmaceutical, medical device, food supplement, cosmetic, and biotech companies across the EU, CIS, and EAEU.
- Company typePrivate
- Founded2003
- HeadquartersRiga, Latvia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Inpharmatis does
Inpharmatis is a privately held international consulting group headquartered in Riga, Latvia, providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, training, and patient information leaflet readability testing services to pharmaceutical, medical device, food supplement, cosmetic, and biotechnology companies. The firm operates across more than 70 countries spanning the EU, CIS, EAEU, Baltic, Caucasus, and Central Asian regulatory regimes, supported by offices in Riga, Tashkent (a representative office established in 2021 and an LLC legal entity opened in November 2024), and Kiev, with a multidisciplinary team of doctors, pharmacists, chemists, and PhD holders working in more than 20 languages. Its proprietary product, PRUDENTA, is a cloud-based pharmacovigilance platform with artificial intelligence integration that supports local medical literature monitoring, validated search workflows, and electronic access to published articles for adverse drug reaction surveillance, and was developed with funding from an EU Commission grant (Agreement No. 828084).
The company generates revenue primarily through project-based professional services engagements and multi-year retainer contracts priced on scope and geographic coverage, with a secondary subscription/usage-based revenue stream from PRUDENTA. Go-to-market is enterprise field sales supported by active participation in major industry conferences (CPHI, RAPS, ISPE, TOPRA, DIA) and direct engagement via phone, email, and industry webinars. The firm has built an authorized partnership portfolio that includes LORENZ Life Sciences (eCTD and RIM solutions across 15 countries), DOT Compliance (AI-powered eQMS), and EPISTA Life Science (computer system validation software), allowing it to resell complementary technology alongside its consulting engagements. Inpharmatis reports 5,500+ completed projects and 500+ customers cumulatively, with no public revenue, funding, or valuation disclosure.
Inpharmatis firmographics
Firmographics- Name
- Inpharmatis
- Legal name
- Inpharmatis SIA
- Website
- https://inpharmatis.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Inpharmatis is a Latvia-based international consulting group providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, and PIL readability testing to pharmaceutical, medical device, food supplement, cosmetic, and biotech companies across the EU, CIS, and EAEU.
- Ownership category
- akta.pro rank
Inpharmatis industry classification
Industry- Product category
- Pharmaceutical Regulatory Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industry
- Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
Keywords
Where Inpharmatis is headquartered
LocationHeadquarters
- HQ city
- Riga
- HQ country
- Latvia
- HQ region
- Europe
Offices3 records
Markets served
Inpharmatis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Regulatory Affairs Consulting Services: Professional consulting services for pharmaceutical product registration, dossier preparation, regulatory strategy development, and lifecycle management across EU, CIS, and EAEU markets. Revenue generated through project-based engagements and retainer arrangements.
- Pharmacovigilance Services: Full scope of pharmacovigilance consulting including QPPV/LPPV services, PSMF creation, case processing, literature monitoring, and signal management. Provided to pharmaceutical companies operating in regulated markets.
- Quality Management & GMP/GDP Audits: Consulting services for GMP/GDP compliance including pre-audits, inspection support, and QMS development. Sale of ready-made GMP audit reports of API manufacturers.
- eCTD Publishing Services: Electronic submission management and publishing services for regulatory dossiers. Handles dossier compilation, formatting, lifecycle management, and submission through regulatory portals.
- Training Services: In-house and customized training programs for regulatory affairs, pharmacovigilance, and GMP/GDP compliance. Offered as off-the-shelf, tailored, or bespoke programs.
- PIL Readability User Testing: User testing services for patient information leaflets according to EAEU requirements, including bridging studies and GAP analysis.
- PRUDENTA Software Solution: Cloud-based AI-powered solution for monitoring adverse drug reactions in local medical literature. Subscription or usage-based access to the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Inpharmatis product offering
Product offeringCore offering
Inpharmatis is an international consulting group providing full-cycle pharmaceutical regulatory services including Regulatory Affairs, Pharmacovigilance, GMP/GDP audits, eCTD publishing, and training for pharmaceutical, biotech, medical device, food supplement, and cosmetic companies across EU, CIS, and EAEU markets. The company also develops PRUDENTA, a proprietary cloud-based AI-powered pharmacovigilance solution for local medical literature monitoring, funded by European Commission Grant Agreement No. 828084.
Product overview
Inpharmatis is an international consulting group providing full-cycle services in Regulatory Affairs, Pharmacovigilance, Quality Management (GMP/GDP), and electronic solutions for the Life Science industry. The company's service portfolio includes: Regulatory Affairs Services covering EU, CIS, and EAEU markets; Pharmacovigilance Services with QPPV/LPPV provision and literature monitoring; Quality Management & GMP/GDP Audits; eCTD Publishing Service; Training Programs; and PIL Readability User Testing. The company also offers PRUDENTA, a proprietary cloud-based pharmacovigilance solution with AI integration for local literature monitoring. Through strategic partnerships, Inpharmatis provides access to LORENZ eCTD/RIM solutions (docuBridge, drugTrack, eValidator), DOT Compliance AI-powered eQMS, and EPISTA validation software.
Differentiator
Problem solved
Functional benefit
Brands
- PRUDENTA: Cloud-based pharmacovigilance solution for monitoring adverse drug reactions in local medical literature with AI integration and validated workflow processes.
Products and services
- Regulatory Affairs Services Comprehensive consultancy services for registration of medicines, medical devices, food supplements, and cosmetics across Europe, CIS, and EAEU regions, including project management, regulatory strategy development, dossier preparation, and SmPC/PIL development for pharmaceutical companies.
- Pharmacovigilance Services Full scope of pharmacovigilance consulting services including QPPV/LPPV provision, PV system creation and management, auditing, PSUR/RMP reports, signal management, and local medical literature monitoring in EU, CIS, and EAEU regions for pharmaceutical companies.
- Quality Management & GMP/GDP Audits Quality management consulting services including QMS development, GMP/GDP consulting, QA services, QP services, GMP/GDP audits of manufacturers, and preparation for EU/EAEU inspections for pharmaceutical manufacturers.
- eCTD Publishing Service Regulatory eCTD submission management and publishing services supporting full product lifecycle from initial submission to renewals and variations, with submissions handled to EMA, FDA, Swissmedic, Ukraine, MHRA, and EAEU.
- Training Services In-house regulatory affairs, pharmacovigilance, and GMP/GDP training programs offered in off-the-shelf, tailored, and bespoke formats for pharmaceutical industry professionals.
- PIL Readability User Testing Patient Information Leaflet (PIL) readability testing according to EAEU requirements with guaranteed acceptance rates, including GAP analysis, bridging studies, and translation services for pharmaceutical companies.
- PRUDENTA Pharmacovigilance Platform Cloud-based AI-powered pharmacovigilance solution for monitoring adverse drug reactions in local medical literature, with electronic access to published articles, validated workflow processes, and quality control checks for pharmaceutical companies.
Quantifiable outcome
- 5,500+ successfully completed projects
- +3 more outcomes
Companies that use Inpharmatis
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
Inpharmatis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
Inpharmatis partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- LORENZ Life Sciences GroupcoreOfficial LORENZ Partner authorised to promote and implement LORENZ eCTD and Regulatory Information Management (RIM) solutions including docuBridge, drugTrack, and eValidator in Turkey, Ukraine, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Uzbekistan, Turkmenistan, Mongolia, Latvia, Lithuania, and Estonia. LORENZ develops leading RIM solutions for Life Sciences since 1989 with over 1800 installations in 48 countries.
- DOT CompliancecorePartnership with DOT Compliance - the first ready-to-use AI-powered eQMS for Life Science Industry. Provides cloud-based quality management system solutions for rapid implementation and quality insights.
- EPISTA Life SciencesupportingPartnership with EPISTA Life Science for software solutions that automate and accelerate validation of computer systems in the pharmaceutical industry.
Scale indicators5 records
Recent moves9 records
Expansion highlights5 records
Inpharmatis competitors and assessment
Company assessmentBroad incumbents
- PharmaLex: PharmaLex is a larger, established regulatory affairs, pharmacovigilance, and quality management consultancy serving pharma and biotech globally. Direct overlap with Inpharmatis's full-service regulatory + PV + GMP offering, but at significantly greater scale and broader geographic footprint; recently acquired by Cencora, increasing competitive intensity.
- CROMSOURCE: CROMSOURCE is an established mid-sized CRO providing clinical, regulatory, and pharmacovigilance services across Europe and emerging markets. Comparable EU + CIS service mix to Inpharmatis but with broader clinical CRO capabilities and larger headcount.
Direct peers
- Arriello: Arriello is a regulatory affairs and pharmacovigilance consultancy with strong EU and emerging-markets presence, offering dossier preparation, local QPPV services, and PV operations. Closely comparable to Inpharmatis in service mix, customer profile (mid-market pharma), and multi-jurisdictional regulatory coverage.
- Apcer Life Sciences: Apcer provides pharmacovigilance, regulatory affairs, and quality compliance services to pharma and medical device companies globally. Direct overlap with Inpharmatis in PV operations, regulatory consulting, and quality management services.
- Pharmexon: Pharmexon is a regulatory affairs and pharmacovigilance consultancy supporting pharma clients across EU and international markets. Closely comparable boutique regulatory services model and similar target customer profile to Inpharmatis.
- Regulis Consulting: Regulis is a regulatory affairs and pharmacovigilance consultancy providing EU and international market access services to pharma and biotech clients. Direct peer in service scope (registration, PV, QPPV) and customer segment.
- Diapharm: Diapharm is a regulatory affairs, quality management, and pharmacovigilance consultancy focused on pharma, medical devices, and consumer health. Comparable boutique scale and EU-centric service portfolio with similar clientele to Inpharmatis.
Emerging players
- PharmEng Technology: PharmEng Technology provides GMP compliance, validation, and regulatory consulting to pharma manufacturers. Overlaps with Inpharmatis's quality management and GMP/GDP audit services, particularly for API manufacturers seeking international registrations.
Others
- DOT Compliance: DOT Compliance provides AI-powered electronic Quality Management System (eQMS) software for the life sciences industry. Technology partner of Inpharmatis for QMS implementations, with partial competitive overlap on quality management consulting.
- LORENZ Life Sciences Group: LORENZ is a software vendor of eCTD and Regulatory Information Management (RIM) solutions used across life sciences. Inpharmatis is an authorized implementation partner for LORENZ, so this is a technology partner rather than competitor, but adjacent in the regulatory workflow Inpharmatis serves.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Inpharmatis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Inpharmatis leadership team
Management profileNumber of profiles
Profiles7 records
Inpharmatis subsidiaries and ownership
Company hierarchySubsidiaries2 records
Inpharmatis funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Inpharmatis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Inpharmatis
What does Inpharmatis do?
Inpharmatis is an international consulting group providing full-cycle pharmaceutical regulatory services including Regulatory Affairs, Pharmacovigilance, GMP/GDP audits, eCTD publishing, and training for pharmaceutical, biotech, medical device, food supplement, and cosmetic companies across EU, CIS, and EAEU markets. The company also develops PRUDENTA, a proprietary cloud-based AI-powered pharmacovigilance solution for local medical literature monitoring, funded by European Commission Grant Agreement No. 828084.
Is Inpharmatis a public or private company?
Inpharmatis is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Inpharmatis founded?
Inpharmatis was founded in 2003. It employs 11 to 50 people.
Where is Inpharmatis based?
Inpharmatis is headquartered in Riga, Latvia, in the Europe region.
How does Inpharmatis make money?
Seven revenue lines are on record. Regulatory Affairs Consulting Services are the primary driver. The others are pharmacovigilance Services, quality Management & GMP/GDP Audits, eCTD Publishing Services, training Services, PIL Readability User Testing and PRUDENTA Software Solution.
Who are Inpharmatis's main competitors?
Broad incumbents on record are PharmaLex and CROMSOURCE. Direct peers are Arriello, Apcer Life Sciences, Pharmexon, Regulis Consulting and Diapharm. PharmEng Technology is listed as an emerging player. Others are DOT Compliance and LORENZ Life Sciences Group.
Does Inpharmatis have an API?
No public API is recorded for Inpharmatis.
What industry is Inpharmatis in?
Inpharmatis's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 54169 and its SIC code is 8090.